Sinha-Hikim Indrani, Cornford Marcia, Gaytan Hilda, Lee Martin L, Bhasin Shalender
Division of Endocrinology, Metabolism, and Molecular Medicine, Charles R. Drew University, Los Angeles, CA 90059, USA.
J Clin Endocrinol Metab. 2006 Aug;91(8):3024-33. doi: 10.1210/jc.2006-0357. Epub 2006 May 16.
In this study, we determined the effects of graded doses of testosterone on muscle fiber cross-sectional area (CSA) and satellite cell number and replication in older men.
Healthy men, 60-75 yr old, received a long-acting GnRH agonist to suppress endogenous testosterone production and 25, 50, 125, 300, or 600 mg testosterone enanthate im weekly for 20 wk.
Immunohistochemistry, light and confocal microscopy, and electron microscopy were used to perform fiber typing and quantitate myonuclear and satellite cell number in vastus lateralis biopsies, obtained before and after 20 wk of treatment.
Testosterone administration in older men was associated with dose-dependent increases in CSA of both types I and II fibers. Satellite cell number increased dose dependently at the three highest doses (3% at baseline vs. 6.2, 9.2, and 13.0% at 125, 300, and 600 mg doses, P < 0.05). Testosterone administration was associated with an increase in the number of proliferating cell nuclear antigen+ satellite cells (1.8% at baseline vs. 3.9, 7.5, and 13% at 125, 300, and 600 mg doses, P < 0.005). The expression of activated Notch, examined only in the 300-mg group (baseline, 2.3 vs. 9.0% after treatment, P < 0.005), increased in satellite cells after testosterone treatment. The expression of myogenin (baseline, 6.2 vs. 20.7% after treatment, P < 0.005), examined only in the 300-mg group, increased significantly in muscle fiber nuclei after testosterone treatment, but Numb expression did not change.
Older men respond to graded doses of testosterone with a dose-dependent increase in muscle fiber CSA and satellite cell number. Testosterone-induced skeletal muscle hypertrophy in older men is associated with increased satellite cell replication and activation.
在本研究中,我们确定了不同剂量睾酮对老年男性肌纤维横截面积(CSA)以及卫星细胞数量和增殖的影响。
60 - 75岁的健康男性,接受长效促性腺激素释放激素(GnRH)激动剂以抑制内源性睾酮生成,并每周一次肌肉注射25、50、125、300或600mg庚酸睾酮,共20周。
使用免疫组织化学、光学和共聚焦显微镜以及电子显微镜对治疗20周前后获取的股外侧肌活检样本进行纤维分型,并对肌核和卫星细胞数量进行定量分析。
老年男性使用睾酮与I型和II型纤维的CSA呈剂量依赖性增加有关。在三个最高剂量下,卫星细胞数量呈剂量依赖性增加(基线时为3%,125、300和600mg剂量时分别为6.2%、9.2%和13.0%,P < 0.05)。使用睾酮与增殖细胞核抗原阳性卫星细胞数量增加有关(基线时为1.8%,125、300和600mg剂量时分别为3.9%、7.5%和13%,P < 0.005)。仅在300mg组检测的活化Notch表达(基线时为2.3%,治疗后为9.0%,P < 0.005)在睾酮治疗后卫星细胞中增加。仅在300mg组检测的生肌调节因子表达(基线时为6.2%,治疗后为20.7%,P < 0.005)在睾酮治疗后肌纤维核中显著增加,但Numb表达未改变。
老年男性对不同剂量睾酮的反应是肌纤维CSA和卫星细胞数量呈剂量依赖性增加。睾酮诱导的老年男性骨骼肌肥大与卫星细胞复制和活化增加有关。